Significant disparities in ovarian cancer exist across the spectrum of care. More specifically, decreased survival, advanced stage at diagnosis, adherence to guideline concordant care, and undergoing genetic testing all may be influenced by factors such as race/ethnicity, insurance status, socioeconomic status, hospital characteristics and rurality.

This webinar will help recognize some of these disparities and shed light on mitigation strategies. Topics discussed include:

• Barriers to access of guideline concordant care in community/rural settings vs that practiced in large metro areas with larger cancer centers
• Creation of a comprehensive support team to ensure access to and delivery of quality care. This will include a discussion on building a team around nurse navigators, chemotherapy administrators and nurses, clinical teams, nutritionists, and genetic counselors
• The unique patient challenges in community settings such as travel difficulty, language barriers, cultural and spiritual differences, and being a member of a disadvantaged minority group
   

Speakers:
Mazen Khalil, MD, St. Bernards Cancer Center
Jeffrey Hines, MD, University of Connecticut Health System
Mandy Gordon, APRN, St. Bernards Cancer Center
Todd Tillmanns, MD, FACOG, West Cancer Center
Leigha Senter, MS, LGC, The Ohio State University

Moderator:
William Burke, MD, Stony Brook Medicine

Recorded on July 28, 2022.

Keywords: ovary, ovarian cancer, disparities, genetic testing, barriers to care


This is an educational resource produced through collaboration between the Society of Gynecologic Oncology (SGO) and the Association of Community Cancer Centers (ACCC). 

     


This activity is supported by independent medical education grants from AstraZeneca and Merck.